Dachaigh › Lymphoma Cealla-B › Illinois › Chicago
Sgrùdaidhean clionaigeach Lymphoma Cealla-B ann an Chicago, IL
Tha 12 sgrùdaidhean airson Lymphoma Cealla-B a’ lorg phàirtichean aig làraichean ann agus timcheall air Chicago (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
A’ fastadhÌre 3
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
A’ fastadhÌre 1
- The University of Chicago Medical Center (UCMC), Chicago
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
A’ fastadhÌre 2
- Research Site, Chicago
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
A’ fastadhÌre 1
- University of Chicago Comprehensive Cancer Center, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
A’ fastadhÌre 1/2
- University of Chicago Medical Center, Chicago
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
A’ fastadhÌre 1
- The David and Etta Jonas Center for Cellular Therapy, Chicago
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A’ fastadhÌre 3
- Northwestern, Chicago
- University of Chicago, Chicago
DALY II USA/ MB-CART2019.1 for DLBCL
A’ fastadhÌre 2
- Robert H Lurie Cancer Center, Chicago
Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma
A’ fastadhÌre 2
- Northwestern University, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
A’ fastadhÌre 1/2
- University of Illinois at Chicago Cancer Center, Chicago
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
A’ fastadhÌre 1/2
- The University of Chicago Medical Center (UCMC), Chicago
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
A’ fastadhÌre 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Sgrùdaidhean Lymphoma Cealla-B ann am bailtean eile
- New York City, NY19 sgrùdaidhean
- Houston, TX16 sgrùdaidhean
- Nashville, TN11 sgrùdadh
- Philadelphia, PA11 sgrùdadh
- Rochester, MN10 sgrùdaidhean
- Baldwin Park, CA9 sgrùdaidhean
- Milwaukee, WI9 sgrùdaidhean
- Cleveland, OH9 sgrùdaidhean
- Salt Lake City, UT8 sgrùdaidhean
- Boston, MA8 sgrùdaidhean
- Columbus, OH7 sgrùdaidhean
- Pittsburgh, PA7 sgrùdaidhean
Sgrùdaidhean eile ann an Chicago
- Aillse Sgamhain Neo-chealla-beag61 sgrùdaidhean
- Aillse a' bhroilleach58 sgrùdaidhean
- Aillse (gach seòrsa)51 sgrùdaidhean
- Ailse metastatach45 sgrùdaidhean
- Aillse Prostata45 sgrùdaidhean
- Obesity41 sgrùdaidhean
- Ailseachadh nan Sgamhan41 sgrùdaidhean
- Cancer Ovarian36 sgrùdaidhean
- Buailteach34 sgrùdaidhean
- Aillse colorectal33 sgrùdaidhean
- Fàilligeadh a' Chridhe31 sgrùdaidhean
- Ro-throm28 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.